Parastremmatic dysplasia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2646OMIM:168400
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Parastremmatic dysplasia (also known as parastremmatic dwarfism) is an extremely rare skeletal dysplasia characterized by severe dwarfism with distortion and twisting of the bones, particularly affecting the long bones, spine, and pelvis. The name derives from the Greek word 'parastremma,' meaning distortion or twisting. This condition is present from birth and becomes progressively apparent during childhood as skeletal deformities worsen. The hallmark features of parastremmatic dysplasia include severe short stature (dwarfism), kyphoscoliosis (abnormal curvature of the spine), bowing and twisting of the limbs, and contractures of major joints. Radiographic findings are distinctive and include irregular, dense areas of bone (sclerotic changes) alongside areas of decreased bone density, giving a characteristic mottled appearance. The long bones show severe metaphyseal and diaphyseal distortion. The vertebral bodies are flattened (platyspondyly) and irregular. Affected individuals may also experience restricted joint mobility and significant skeletal pain. Parastremmatic dysplasia has been associated with mutations in the TRPV4 gene, which encodes a calcium-permeable ion channel involved in bone development and homeostasis. There is currently no cure or disease-specific treatment. Management is supportive and symptomatic, focusing on orthopedic interventions to address skeletal deformities, physical therapy to maintain mobility, pain management, and monitoring for potential complications. Surgical correction of severe bowing or spinal deformities may be considered in some cases.

Also known as:

Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Parastremmatic dysplasia.

View clinical trials →

No actively recruiting trials found for Parastremmatic dysplasia at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Parastremmatic dysplasia community →

No specialists are currently listed for Parastremmatic dysplasia.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Parastremmatic dysplasia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Parastremmatic dysplasiaForum →

No community posts yet. Be the first to share your experience with Parastremmatic dysplasia.

Start the conversation →

Latest news about Parastremmatic dysplasia

No recent news articles for Parastremmatic dysplasia.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Parastremmatic dysplasia

What is Parastremmatic dysplasia?

Parastremmatic dysplasia (also known as parastremmatic dwarfism) is an extremely rare skeletal dysplasia characterized by severe dwarfism with distortion and twisting of the bones, particularly affecting the long bones, spine, and pelvis. The name derives from the Greek word 'parastremma,' meaning distortion or twisting. This condition is present from birth and becomes progressively apparent during childhood as skeletal deformities worsen. The hallmark features of parastremmatic dysplasia include severe short stature (dwarfism), kyphoscoliosis (abnormal curvature of the spine), bowing and twi

How is Parastremmatic dysplasia inherited?

Parastremmatic dysplasia follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Parastremmatic dysplasia typically begin?

Typical onset of Parastremmatic dysplasia is neonatal. Age of onset can vary across affected individuals.